orBec, oral corticosteroid beclomethasone dipropionate to treat gastrointestinal manifestation of Graft-versus-Host disease (GVHD) has entered into phase 2 clinical study, Soligenix, Inc announced.
Zydus Cadila will soon launch India's first indigenously made H1N1 swine flu vaccine VaxiFlu-S in the country.
Suven Life Sciences Ltd, a contract reserach and manufacturing services provider from India, has received Canadian and Eurasian patents for new chemical compounds with potential to treat several neurodegenerative diseases including Alzheimer's.
Daiichi-controlled Ranbaxy Laboratories has posted strong bottom line during the first quarter ended March 2010, thanks to winfall revenues from generic valacyclovir (Valtrex).
Unichem Laboratories has reported over 7% growth in sales and profits during the year ended March 2010.
Indian generics firm Strides Acrolab has received US Food and Drug Administration's approval for marketing and distributing bacitracin injections in US.
India is likely to bring in all kinds of vaccines under drug price control, reports indicate.